Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Food Insecurity as a Risk Factor for Outcomes Related to Ebola Virus Disease in Kono District, Sierra Leone: A Cross-Sectional Study.
Kelly JD, Richardson ET, Drasher M, Barrie MB, Karku S, Kamara M, Hann K, Dierberg K, Hubbard A, Lindan CP, Farmer PE, Rutherford GW, Weiser SD. Kelly JD, et al. Among authors: kamara m. Am J Trop Med Hyg. 2018 May;98(5):1484-1488. doi: 10.4269/ajtmh.17-0820. Epub 2018 Mar 15. Am J Trop Med Hyg. 2018. PMID: 29557329 Free PMC article.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Afolabi MO, Ishola D, Manno D, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Greenwood B, Leyssen M, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group. Afolabi MO, et al. Lancet Infect Dis. 2022 Jan;22(1):110-122. doi: 10.1016/S1473-3099(21)00128-6. Epub 2021 Sep 13. Lancet Infect Dis. 2022. PMID: 34529962 Free PMC article. Clinical Trial.
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
Ishola D, Manno D, Afolabi MO, Keshinro B, Bockstal V, Rogers B, Owusu-Kyei K, Serry-Bangura A, Swaray I, Lowe B, Kowuor D, Baiden F, Mooney T, Smout E, Köhn B, Otieno GT, Jusu M, Foster J, Samai M, Deen GF, Larson H, Lees S, Goldstein N, Gallagher KE, Gaddah A, Heerwegh D, Callendret B, Luhn K, Robinson C, Leyssen M, Greenwood B, Douoguih M, Leigh B, Watson-Jones D; EBL3001 study group. Ishola D, et al. Lancet Infect Dis. 2022 Jan;22(1):97-109. doi: 10.1016/S1473-3099(21)00125-0. Epub 2021 Sep 13. Lancet Infect Dis. 2022. PMID: 34529963 Free PMC article. Clinical Trial.
Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study.
Kelly JD, Frankfurter RG, Tavs JM, Barrie MB, McGinnis T, Kamara M, Freeman A, Quiwah K, Davidson MC, Dighero-Kemp B, Gichini H, Elliott E, Reilly C, Hensley LE, Lane HC, Weiser SD, Porco TC, Rutherford GW, Richardson ET. Kelly JD, et al. Among authors: kamara m. Open Forum Infect Dis. 2022 Mar 7;9(4):ofac052. doi: 10.1093/ofid/ofac052. eCollection 2022 Apr. Open Forum Infect Dis. 2022. PMID: 35265726 Free PMC article.
A post-outbreak assessment of exposure proximity and Ebola virus disease-related stigma among community members in Kono District, Sierra Leone: A cross-sectional study.
Davidson MC, Lu S, Barrie MB, Freeman A, Mbayoh M, Kamara M, Tsai AC, Crea T, Rutherford GW, Weiser SD, Kelly JD. Davidson MC, et al. Among authors: kamara m. SSM Ment Health. 2022 Dec;2:100064. doi: 10.1016/j.ssmmh.2022.100064. Epub 2022 Jan 29. SSM Ment Health. 2022. PMID: 35449727 Free PMC article.
Social Network Analysis of Ebola Virus Disease During the 2014 Outbreak in Sukudu, Sierra Leone.
Hazel A, Davidson MC, Rogers A, Barrie MB, Freeman A, Mbayoh M, Kamara M, Blumberg S, Lietman TM, Rutherford GW, Jones JH, Porco TC, Richardson ET, Kelly JD. Hazel A, et al. Among authors: kamara m. Open Forum Infect Dis. 2022 Nov 3;9(11):ofac593. doi: 10.1093/ofid/ofac593. eCollection 2022 Nov. Open Forum Infect Dis. 2022. PMID: 36467298 Free PMC article.
Bringing the social into vaccination research: Community-led ethnography and trust-building in immunization programs in Sierra Leone.
Enria L, Bangura JS, Kanu HM, Kalokoh JA, Timbo AD, Kamara M, Fofanah M, Kamara AN, Kamara AI, Kamara MM, Suma IS, Kamara OM, Kamara AM, Kamara AO, Kamara AB, Kamara E, Lees S, Marchant M, Murray M. Enria L, et al. Among authors: kamara m, kamara ai, kamara ab, kamara an, kamara e, kamara om, kamara ao, kamara mm, kamara am. PLoS One. 2021 Oct 22;16(10):e0258252. doi: 10.1371/journal.pone.0258252. eCollection 2021. PLoS One. 2021. PMID: 34679104 Free PMC article.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Among authors: kamara ab, kamara mm. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
109 results